[Limitations and risks of therapy of psoriasis with amethopterin and hydroxyurea].
D000328:Adult; D000368:Aged; D001778:Blood Coagulation Disorders / Q000209:etiology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002869:Chromosome Aberrations / Q000209:etiology; D025063:Chromosome Disorders; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D011704:Pyelonephritis / Q000209:etiology
D006918:Hydroxyurea; D008727:Methotrexate
Limiti e pericoli della terapia della psoriasi con ametopterina ed idrossiurea.